It's not a cure, but the drug, given intravenously every 2 weeks, has shown moderate positive effects in clinical trials in slowing early-stage disease.
from WebMD Health https://www.webmd.com/alzheimers/news/20230106/what-to-know-about-new-alzheimers-drug?src=RSS_PUBLIC
0 Comments:
Post a Comment